346 related articles for article (PubMed ID: 16049570)
1. Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition.
El Mansari M; Blier P
J Psychiatry Neurosci; 2005 Jul; 30(4):268-74. PubMed ID: 16049570
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; De Montigny C; Blier P
Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
4. Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study.
Bergqvist PB; Dong J; Blier P
Psychopharmacology (Berl); 1999 Mar; 143(1):89-96. PubMed ID: 10227084
[TBL] [Abstract][Full Text] [Related]
5. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
6. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder.
el Mansari M; Bouchard C; Blier P
Neuropsychopharmacology; 1995 Oct; 13(2):117-27. PubMed ID: 8597523
[TBL] [Abstract][Full Text] [Related]
7. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
9. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
Castro E; Tordera RM; Hughes ZA; Pei Q; Sharp T
J Neurochem; 2003 Jun; 85(6):1480-7. PubMed ID: 12787067
[TBL] [Abstract][Full Text] [Related]
10. A selective serotonin reuptake inhibitor ameliorates obsessive-compulsive disorder-like perseverative behavior by attenuating 5-HT
Hatakama H; Asaoka N; Nagayasu K; Shirakawa H; Kaneko S
Neuropharmacology; 2022 Mar; 206():108926. PubMed ID: 34921828
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
Chaput Y; de Montigny C; Blier P
Neuropsychopharmacology; 1991 Dec; 5(4):219-29. PubMed ID: 1839498
[TBL] [Abstract][Full Text] [Related]
12. Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.
Szabo ST; Blier P
Brain Res; 2001 Dec; 922(1):9-20. PubMed ID: 11730697
[TBL] [Abstract][Full Text] [Related]
13. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
Froger N; Gardier AM; Moratalla R; Alberti I; Lena I; Boni C; De Felipe C; Rupniak NM; Hunt SP; Jacquot C; Hamon M; Lanfumey L
J Neurosci; 2001 Oct; 21(20):8188-97. PubMed ID: 11588191
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis.
Moret C; Briley M
J Neural Transm (Vienna); 1997; 104(2-3):147-60. PubMed ID: 9203078
[TBL] [Abstract][Full Text] [Related]
16. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
Sakaue M; Somboonthum P; Nishihara B; Koyama Y; Hashimoto H; Baba A; Matsuda T
Br J Pharmacol; 2000 Mar; 129(5):1028-34. PubMed ID: 10696105
[TBL] [Abstract][Full Text] [Related]
17. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
Hjorth S; Auerbach SB
Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519
[TBL] [Abstract][Full Text] [Related]
18. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
Kantor S; Graf M; Anheuer ZE; Bagdy G
Eur Neuropsychopharmacol; 2001 Feb; 11(1):15-24. PubMed ID: 11226808
[TBL] [Abstract][Full Text] [Related]
19. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
Béïque JC; Blier P; de Montigny C; Debonnel G
Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
